Table 4.
Recurrences, sustained response, relapses, sustained pain-free and use of second dose (intention-to-treat sample)*
| First attack | Second attack | Total attacks | ||||
|---|---|---|---|---|---|---|
| Indoprocaf | Sumatriptan | Indoprocaf | Sumatriptan | Indoprocaf | Sumatriptan | |
| Recurrences (24 h) | 16/82 (20) | 19/79 (24) | 16/88 (18) | 16/70 (23) | 32/170 (19) | 35/149 (24) |
| Sustained response | 64/143 (45) | 60/138 (44) | 72/133 (54) | 54/126 (43) | 136/276 (49) | 114/264 (43) |
| Relapses (48 h) | 22/45 (49) | 20/49 (41) | 16/48 (33) | 13/49 (27) | 38/93 (41) | 33/98 (34) |
| Sustained pain-free | 23/143 (16) | 29/138 (21) | 32/133 (24) | 35/126 (28) | 55/276 (20) | 64/264 (24) |
| Use of second dose asrescue medication (2–48 h) | 46/143 (32) | 43/138 (31) | 25/133 (19) | 42/126 (33) | 71/276 (26) | 85/264 (32) |
| Use of second doseto treat a recurrence/relapse | 26/143 (18) | 23/138 (17) | 19/133 (14) | 19/126 (15) | 45/276 (16) | 42/264 (16) |
*
Values are number of attacks complying with the parameter/total no. of attacks (percentage). Indoprocaf indicates indomethacin, prochlorperazine and caffeine.